<DOC>
	<DOCNO>NCT01480648</DOCNO>
	<brief_summary>This first-in-man trial form basis potential clinical development BI 144807 indication asthma allergic rhinitis . The safety , tolerability , pharmacokinetics , pharmacodynamics single rise dos BI 144807 assess healthy male volunteer .</brief_summary>
	<brief_title>Single Rising Dose Study BI 144807 Powder Bottle Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : 1. healthy male subject Exclusion criterion : 1. relevant deviation healthy condition</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>